Status:
COMPLETED
Sleep Extension or Regularity to Reduce Diabetes Risk
Lead Sponsor:
University of Chicago
Conditions:
Overweight or Obesity
Eligibility:
All Genders
21-50 years
Phase:
NA
Brief Summary
The goal of this study is to identify an intervention that improves sleep health and consequently metabolic health by examining whether sleep extension or enforced regularity in short sleepers will ha...
Detailed Description
Numerous studies of restricted sleep have revealed insufficient sleep as a novel risk factor for metabolic disease. Specifically, it has been reported that insufficient sleep resulted in impairments i...
Eligibility Criteria
Inclusion
- African American or Black men and women
- Age 21-50 years old
- Overweight (BMI greater than or equal 25 kg/m2 and less than 35 kg/m2)
- Self-reported short sleep (less than 7hrs/night, sleep between 22:00-08:00, and who indicate they could sleep more if they had the opportunity)
- No previously diagnosed sleep disorders (including obstructive sleep apnea (OSA))
- No existing diagnosis of diabetes
- No history of endocrine dysfunction
- No history of psychiatric, cardiovascular, or eating disorders, not having a gastro-intestinal disease that requires dietary adjustment,
- Currently taking no medications (excluding statins and birth control)
Exclusion
- Drug and nicotine use
- Habitual alcohol use of more than 2 drinks per day
- Caffeine intake of more than 500 mg per day
- Subjects who participated in medically managed weight loss program within the past year
- Subjects who have undergone bariatric surgery,
- Subjects who have dietary restrictions,
- Subjects who worked night shifts, or crossed any time zones in the month prior to the study.
- Sleep-disordered breathing (apnea-hypopnea index\>15 events/hour) from an overnight at home sleep test (NOX)
- Peri- and post-menopausal women will not be included.
Key Trial Info
Start Date :
January 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06128265
Start Date
January 3 2024
End Date
December 31 2024
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637